峰表媒通过Sirt1的二基化,通过对抗CYLD的NF-kB激活来缓解类风湿性关节炎

Zhiming Wu1, Peng Zhang1, Wenyan Huang2

  • 1Chinese Medicine Department, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330000, Jiangxi Province, PR China.

Immunobiology
|February 5, 2025
PubMed
概括

昆 (Qufeng) (epimedium) 疗法通过减少炎症和细胞死亡来治疗类风湿性关节炎 (RA). 它通过通过CYLD稳定Sirt1,抑制NF-kB/GSDMD通路而起作用.